nach oben

Erschienen in:

06.12.2023 | Original Article

Tea consumption and risk of bone health: an updated systematic review and meta-analysis

verfasst von: Fuding Zhou, Ting Wang, Lexun Li, Jinchuan Yu, Zhengxiang Liu, Jianghui Zhang, Guangjun Wang, Jiujiu Li, Changsheng Shao, Peng Wang, Wenjun Chen

Erschienen in: Journal of Bone and Mineral Metabolism | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Current research evaluating the association between tea consumption and bone health still has inconsistent findings.

Materials and Methods

The electronic databases of Embase, PubMed, Scopus, and Web of Science were systematically searched from inception until December 2022 to identify eligible studies. The calculation of summary relative risks (RRs) and 95% confidence intervals (CIs) was carried out using random-effects models. I² statistics and Forest plots were used to assess the heterogeneity of RR values across studies.

Results

The pooled relative risks for bone health-related outcomes of interest among tea drinkers, compared to non-drinkers, were 0.910 (95% confidence interval 0.845 to 0.980) for fractures, based on 20 studies, 0.332 (0.207–0.457) for BMD (13 studies), 0.800 (0.674–0.950) for osteoporosis (10 studies), and 1.006 (0.876–1.156) for osteopenia (5 studies). Subgroup analysis of locations showed that the pooled relative risks were 0.903 (0.844–0.966) for the hip, 0.735 (0.586–0.922) for the femur, 0.776 (0.610–0.988) for the lumbar, 0.980 (0.942–1.021) for the forearm and wrist, 0.804 (0.567–1.139) for the phalanges, and 0.612 (0.468–0.800) for Ward’s triangle. One-stage dose–response analysis revealed that individuals who consumed less than 4.5 cups of tea per day had a lower risk of bone health-related outcomes than those who did not consume tea, with statistically significant results.

Conclusion

There is an association between tea consumption and a reduced risk of fractures, osteoporosis, hip, femur, and lumbar, as well as increased BMD.

Nur mit Berechtigung zugänglich

Harvey N, Dennison E, Cooper C (2010) Osteoporosis: impact on health and economics. Nat Rev Rheumatol 6:99–105PubMedCrossRef

NIH Consensus Development Panel on Osteoporosis Prevention D, Therapy (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785–795CrossRef

Muraki S, Yamamoto S, Ishibashi H, Oka H, Yoshimura N, Kawaguchi H, Nakamura K (2007) Diet and lifestyle associated with increased bone mineral density: cross-sectional study of Japanese elderly women at an osteoporosis outpatient clinic. J Orthop Sci 12:317–320PubMedCrossRef

Guan J, Wu M, Xiao Y, Zhou J, Wang Z (2014) MTHFR C677T polymorphism and osteoporotic fracture in postmenopausal women: a meta-analysis. Genet Mol Res 13:7356–7364PubMedCrossRef

Shen G, Li Y, Zhao G, Zhou H, Xie Z, Xu W, Chen H, Dong Q, Xu Y (2015) Cigarette smoking and risk of hip fracture in women: a meta-analysis of prospective cohort studies. Injury 46:1333–1340PubMedCrossRef

Sun Y, Liu C, Bo Y, You J, Zhu Y, Duan D, Cui H, Lu Q (2018) Dietary vitamin C intake and the risk of hip fracture: a dose-response meta-analysis. Osteoporos Int 29:79–87PubMedCrossRef

Zhang X, Yu Z, Yu M, Qu X (2015) Alcohol consumption and hip fracture risk. Osteoporos Int 26:531–542PubMedCrossRef

Sarma D, Barrett M, Chavez M, Gardiner P, Ko R, Mahady G, Marles R, Pellicore L, Giancaspro G, Low Dog T (2008) Safety of green tea extracts : a systematic review by the US Pharmacopeia. Drug Saf 31:469–484PubMedCrossRef

Inoue-Choi M, Ramirez Y, Cornelis M, Berrington de González A, Freedman N, Loftfield E (2022) Tea consumption and all-cause and cause-specific mortality in the UK biobank: a prospective cohort study. Ann Intern Med 175:1201–1211PubMedPubMedCentralCrossRef

10.

Yang CS, Hong J (2013) Prevention of chronic diseases by tea: possible mechanisms and human relevance. Annu Rev Nutr 33:161–181PubMedCrossRef

11.

Kandinov B, Giladi N, Korczyn AD (2009) Smoking and tea consumption delay onset of Parkinson’s disease. Parkinsonism Relat Disord 15:41–46PubMedCrossRef

12.

Béliveau R, Gingras D (2004) Green tea: prevention and treatment of cancer by nutraceuticals. Lancet 364:1021–1022PubMedCrossRef

13.

Yang C, Wang X, Lu G, Picinich S (2009) Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 9:429–439PubMedPubMedCentralCrossRef

14.

Nash L, Ward W (2017) Tea and bone health: findings from human studies, potential mechanisms, and identification of knowledge gaps. Crit Rev Food Sci Nutr 57:1603–1617PubMedCrossRef

15.

Conforti A, Gallo M, Saraví F (2012) Yerba mate (Ilex paraguariensis) consumption is associated with higher bone mineral density in postmenopausal women. Bone 50:9–13PubMedCrossRef

16.

Hegarty V, May H, Khaw K (2000) Tea drinking and bone mineral density in older women. Am J Clin Nutr 71:1003–1007PubMedCrossRef

17.

Hossein-Nezhad A, Maghbooli Z, Shafaei A, Javadi E, Larijani B (2007) Relationship between tea drinking and bone mineral density in Iranian population. Iran J Public Health 36:57–62

18.

Huang H, Han G, Jing L, Chen Z, Chen Y, Xiao S (2018) Tea consumption is associated with increased bone strength in middle-aged and elderly Chinese women. J Nutr Health Aging 22:216–221PubMedCrossRef

19.

Li J, Ge J, Chen J, Ye Y, Xie L, Li L, Chai H (2021) Clinical study on the influence of tea drinking habits on bone mineral density and osteoporosis in postmenopausal women in Fuzhou city. China Progress in Nutrition 23:e2021033

20.

Chen Z, Pettinger M, Ritenbaugh C, LaCroix A, Robbins J, Caan B, Barad D, Hakim IA (2003) Habitual tea consumption and risk of osteoporosis: a prospective study in the women’s health initiative observational cohort. Am J Epidemiol 158:772–781PubMedCrossRef

21.

Li X, Qiao Y, Yu C, Guo Y, Bian Z, Yang L, Chen Y, Yan S, Xie X, Huang D, Chen J, Chen Z, Lv J, Li L (2019) Tea consumption and bone health in Chinese adults: a population-based study. Osteoporos Int 30:333–341PubMedCrossRef

22.

Hernández-Avila M, Stampfer M, Ravnikar V, Willett W, Schiff I, Francis M, Longcope C, McKinlay S, Longscope C (1993) Caffeine and other predictors of bone density among pre- and perimenopausal women. Epidemiology 4:128–134PubMedCrossRef

23.

Shen Q, Yu C, Guo Y, Bian Z, Zhu N, Yang L, Chen Y, Luo G, Li J, Qin Y, Chen J, Chen Z, Lv J, Li L (2018) Habitual tea consumption and risk of fracture in 0.5 million Chinese adults: a prospective cohort study. Nutrients. 10:1633PubMedPubMedCentralCrossRef

24.

Jha R, Mithal A, Malhotra N, Brown E (2010) Pilot case-control investigation of risk factors for hip fractures in the urban Indian population. BMC Musculoskelet Disord 11:49PubMedPubMedCentralCrossRef

25.

Huang Y, Chen L, Feng S, Liang Y, Pan S (2023) Tea consumption and the risks of osteoporosis and hip fracture: a population-based longitudinal follow-up study. Osteoporos Int 34:101–109PubMedCrossRef

26.

Hsu C, Huang W, Chen H, Cheng-Yen Lai J (2022) Non-fermented tea consumption protects against osteoporosis among Chinese male elders using the Taiwan biobank database. Sci Rep 12:7382ADSPubMedPubMedCentralCrossRef

27.

Xia S, Ma Z, Wang B, Guo S, Zhou X, Gao F (2021) The association between tea consumption and the risk of fracture: a dose-response meta-analysis of prospective cohort studies. J Nutr Health Aging 25:1046–1052PubMedCrossRef

28.

Chen B, Shi H, Wu S (2014) Tea consumption didn’t modify the risk of fracture: a dose-response meta-analysis of observational studies. Diagn Pathol 9:44PubMedPubMedCentralCrossRef

29.

Xiang W, Gu K, Wang W, Jiang X (2019) Tea consumption and risk of fractures: an updated meta-analysis. Osteoporos Int 30:1941–1951PubMedCrossRef

30.

Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605PubMedCrossRef

31.

Zeng X, Zhang Y, Kwong J, Zhang C, Li S, Sun F, Niu Y, Du L (2015) The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med 8:2–10PubMedCrossRef

32.

Stare J, Maucort-Boulch D (2016) Odds Ratio, Hazard Ratio and Relative Risk. Adv Methodol Stat 13:59–67

33.

Zhang J, Yu K (1998) What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 280:1690–1691PubMedCrossRef

34.

Ronksley PE, Brien S, Turner B, Mukamal K, Ghali WA (2011) Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ 342:d671PubMedPubMedCentralCrossRef

35.

Dai Z, Jin A, Soh A, Ang L, Yuan J, Koh W (2018) Coffee and tea drinking in relation to risk of hip fracture in the Singapore Chinese Health Study. Bone 112:51–57PubMedPubMedCentralCrossRef

36.

Hallström H, Wolk A, Glynn A, Michaëlsson K (2006) Coffee, tea and caffeine consumption in relation to osteoporotic fracture risk in a cohort of Swedish women. Osteoporos Int 17:1055–1064PubMedCrossRef

37.

Hansen S, Folsom A, Kushi L, Sellers TA (2000) Association of fractures with caffeine and alcohol in postmenopausal women: the Iowa Women’s Health Study. Public Health Nutr 3:253–261PubMedCrossRef

38.

Hernandez-Avila M, Colditz G, Stampfer M, Rosner B, Speizer F, Willett W (1991) Caffeine, moderate alcohol intake, and risk of fractures of the hip and forearm in middle-aged women. Am J Clin Nutr 54:157–163PubMedCrossRef

39.

Huang C, Tang R (2016) Tea drinking habits and osteoporotic hip/femur fractures: a case-control study. Pak J Med Sci 32:408–412PubMedPubMedCentral

40.

Johnell O, Gullberg B, Kanis J, Allander E, Elffors L, Dequeker J, Dilsen G, Gennari C, Lopes Vaz A, Lyritis G (1995) Risk factors for hip fracture in European women: the MEDOS Study. Mediterranean Osteoporosis Study. J Bone Miner Res 10:1802–1815PubMedCrossRef

41.

Kanis J, Johnell O, Gullberg B, Allander E, Elffors L, Ranstam J, Dequeker J, Dilsen G, Gennari C, Vaz AL, Lyritis G, Mazzuoli G, Miravet L, Passeri M, Perez Cano R, Rapado A, Ribot C (1999) Risk factors for hip fracture in men from southern Europe: the MEDOS study. Mediterranean osteoporosis study. Osteoporos Int 9:45–54PubMedCrossRef

42.

Kiel D, Felson D, Hannan M, Anderson J, Wilson P (1990) Caffeine and the risk of hip fracture: the Framingham study. Am J Epidemiol 132:675–684PubMedCrossRef

43.

Kreiger N, Gross A, Hunter G (1992) Dietary factors and fracture in postmenopausal women: a case-control study. Int J Epidemiol 21:953–958PubMedCrossRef

44.

Myers G, Prince R, Kerr D, Devine A, Woodman R, Lewis J, Hodgson J (2015) Tea and flavonoid intake predict osteoporotic fracture risk in elderly Australian women: a prospective study. Am J Clin Nutr 102:958–965PubMedCrossRef

45.

Nieves J, Grisso J, Kelsey J (1992) A case-control study of hip fracture: evaluation of selected dietary variables and teenage physical activity. Osteoporos Int 2:122–127PubMedCrossRef

46.

Suzuki T, Yoshida H, Hashimoto T, Yoshimura N, Fujiwara S, Fukunaga M, Nakamura T, Yoh K, Inoue T, Hosoi T, Orimo H (1997) Case-control study of risk factors for hip fractures in the Japanese elderly by a Mediterranean Osteoporosis Study (MEDOS) questionnaire. Bone 21:461–467PubMedCrossRef

47.

Tavani A, Negri E, La Vecchia C (1995) Coffee intake and risk of hip fracture in women in northern Italy. Prev Med 24:396–400PubMedCrossRef

48.

Tomata Y, Kakizaki M, Nakaya N, Tsuboya T, Sone T, Kuriyama S, Hozawa A, Tsuji I (2012) Green tea consumption and the risk of incident functional disability in elderly Japanese: the Ohsaki Cohort 2006 Study. Am J Clin Nutr 95:732–739PubMedPubMedCentralCrossRef

49.

Webster J, Greenwood D, Cade J (2022) Foods, nutrients and hip fracture risk: a prospective study of middle-aged women. Clin Nutr 41:2825–2832PubMedCrossRef

50.

Zeng F, Wu B, Fan F, Xie H, Xue W, Zhu H, Chen Y (2013) Dietary patterns and the risk of hip fractures in elderly Chinese: a matched case-control study. J Clin Endocrinol Metab 98:2347–2355PubMedCrossRef

51.

Devine A, Hodgson J, Dick I, Prince R (2007) Tea drinking is associated with benefits on bone density in older women. Am J Clin Nutr 86:1243–1247PubMedCrossRef

52.

Hamdi Kara I, Aydin S, Gemalmaz A, Aktürk Z, Yaman H, Bozdemir N, Kurdak H, Sitmapinar K, Devran Sencar I, Başak O, Akdeniz M, Işildar H, Burgut E, Ozcan S, Akça U, Dağdeviren N, Ungan M (2007) Habitual tea drinking and bone mineral density in postmenopausal Turkish women: investigation of prevalence of postmenopausal osteoporosis in Turkey (IPPOT Study). Int J Vitam Nutr Res 77:389–397PubMedCrossRef

53.

Hsiao M, Liu C, Wang C (2012) Factors associated with low bone density among women with major depressive disorder. Int J Psychiatry Med 44:77–90PubMedCrossRef

54.

Ni S, Wang L, Wang G, Lin J, Ma Y, Zhao X, Ru Y, Zheng W, Zhang X, Zhu S (2021) Drinking tea before menopause is associated with higher bone mineral density in postmenopausal women. Eur J Clin Nutr 75:1454–1464PubMedCrossRef

55.

Wang G, Liu G, Zhao H, Zhang F, Li S, Chen Y, Zhang Z (2014) Oolong tea drinking could help prevent bone loss in postmenopausal Han Chinese women. Cell Biochem Biophys 70:1289–1293PubMedCrossRef

56.

Wu C, Yang Y, Yao W, Lu F, Wu J, Chang C (2002) Epidemiological evidence of increased bone mineral density in habitual tea drinkers. Arch Intern Med 162:1001–1006PubMedCrossRef

57.

Keramat A, Patwardhan B, Larijani B, Chopra A, Mithal A, Chakravarty D, Adibi H, Khosravi A (2008) The assessment of osteoporosis risk factors in Iranian women compared with Indian women. BMC Musculoskelet Disord 9:28PubMedPubMedCentralCrossRef

58.

Keskin Y, Çekin M, Gündüz H, Lüleci N, Giray E, Sur H, Akyüz G (2014) The prevalence of osteoporosis in the Thrace region of Turkey: a community-based study. Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi 60:335–340CrossRef

59.

Lee D, Song H, Paek Y, Park K, Seo Y, Noh H (2021) Relationship between regular green tea intake and osteoporosis in Korean postmenopausal women: a nationwide study. Nutrients 14:87PubMedPubMedCentralCrossRef

60.

Wang S, Lin S, Zhou Y, Wang Z (2008) Social and behavior factors related to aged Chinese women with osteoporosis. Gynecol Endocrinol 24:538–545PubMedCrossRef

61.

Wang Y, Ding H, Wang X, Wei Z, Feng S (2019) Associated factors for osteoporosis and fracture in Chinese elderly. Med Sci Monit 25:5580–5588PubMedPubMedCentralCrossRef

62.

AlQuaiz A, Kazi A, Tayel S, Shaikh SA, Al-Sharif A, Othman S, Habib F, Fouda M, Sulaimani R (2014) Prevalence and factors associated with low bone mineral density in Saudi women: a community based survey. BMC Musculoskelet Disord 15:5PubMedPubMedCentralCrossRef

63.

Chan P, Nurul Z, Chuah J, Nabil M, Isa N, Sabarul A, Nazrun A (2014) Association between risk factors of osteoporosis and bone mineral density in women of different ethnic groups in a Malaysian hospital. Int J Osteoporos Metab Disord 7:1–11CrossRef

64.

Sun K, Wang L, Ma Q, Cui Q, Lv Q, Zhang W, Li X (2017) Association between tea consumption and osteoporosis: a meta-analysis. Medicine (Baltimore) 96:e9034PubMedCrossRef

65.

Zhang Z, Yang J, Jiang H, Lai Z, Wu F, Liu Z (2017) Updated association of tea consumption and bone mineral density: a meta-analysis. Medicine (Baltimore) 96:e6437PubMedCrossRef

66.

Guo M, Qu H, Xu L, Shi D (2017) Tea consumption may decrease the risk of osteoporosis: an updated meta-analysis of observational studies. Nutr Res 42:1–10PubMedCrossRef

67.

Sheng J, Qu X, Zhang X, Zhai Z, Li H, Liu X, Li H, Liu G, Zhu Z, Hao Y, Qin A, Dai K (2014) Coffee, tea, and the risk of hip fracture: a meta-analysis. Osteoporos Int 25:141–150PubMedCrossRef

68.

Lin S, Kang L, Wang C, Huang H, Cheng T, Huang H, Lee M, Lin Y, Ho M, Wang G, Chen C (2018) (-)-Epigallocatechin-3-gallate (EGCG) enhances osteogenic differentiation of human bone marrow mesenchymal stem cells. Molecules 23:3221PubMedPubMedCentralCrossRef

69.

Chen S, Kang L, Wang C, Huang P, Huang H, Lin S, Chou S, Lu C, Shen P, Lin Y, Chen C (2019) (-)-Epigallocatechin-3-gallate decreases osteoclastogenesis via modulation of RANKL and osteoprotegrin. Molecules. 24:156PubMedPubMedCentralCrossRef

70.

Oka Y, Iwai S, Amano H, Irie Y, Yatomi K, Ryu K, Yamada S, Inagaki K, Oguchi K (2012) Tea polyphenols inhibit rat osteoclast formation and differentiation. J Pharmacol Sci 118:55–64PubMedCrossRef

71.

Hao G, Zhang B, Gu M, Chen C, Zhang Q, Zhang G, Cao X (2017) Vitamin K intake and the risk of fractures: a meta-analysis. Medicine (Baltimore) 96:e6725PubMedCrossRef

72.

Parfitt A (2002) Misconceptions (2): turnover is always higher in cancellous than in cortical bone. Bone 30:807–809PubMedCrossRef

73.

Ott S (2018) Cortical or trabecular bone: what’s the difference? Am J Nephrol 47:373–375PubMedCrossRef

74.

Shen C, Chyu M, Wang J (2013) Tea and bone health: steps forward in translational nutrition. Am J Clin Nutr 98:1694s–1699sPubMedPubMedCentralCrossRef

75.

Kannus P, Haapasalo H, Sievänen H, Oja P, Vuori I (1994) The site-specific effects of long-term unilateral activity on bone mineral density and content. Bone 15:279–284PubMedCrossRef

Titel: Tea consumption and risk of bone health: an updated systematic review and meta-analysis
verfasst von: Fuding Zhou
Ting Wang
Lexun Li
Jinchuan Yu
Zhengxiang Liu
Jianghui Zhang
Guangjun Wang
Jiujiu Li
Changsheng Shao
Peng Wang
Wenjun Chen
Publikationsdatum: 06.12.2023
Verlag: Springer Nature Singapore
Erschienen in: Journal of Bone and Mineral Metabolism / Ausgabe 1/2024
Print ISSN: 0914-8779
Elektronische ISSN: 1435-5604
DOI: https://doi.org/10.1007/s00774-023-01479-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Tea consumption and risk of bone health: an updated systematic review and meta-analysis